Penserra Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101M Sell
209,629
-47,159
-18% -$12.5M 0.78% 26
2026
Q1
$28.1M Sell
256,788
-33,016
-11% -$4.7M 0.33% 95
2025
Q4
$48.2M Buy
289,804
+245,330
+552% +$41M 0.57% 45
2025
Q3
$8.71M Sell
44,474
-5,370
-11% -$883K 0.1% 210
2025
Q2
$4.51M Sell
49,844
-9,712
-16% -$767K 0.06% 251
2025
Q1
$3.55M Buy
59,556
+23,565
+65% +$2.18M 0.06% 236
2024
Q4
$4.77M Buy
+35,991
New +$3.38M 0.09% 226

Other funds holding ALAB

Penserra Capital Management's ALAB Position: Q2 2026 in Review

Penserra Capital Management reduced its Astera Labs (ALAB) stake by 18% in Q2 2026, selling an estimated $12.5M and leaving 209,629 shares worth $101M. The position accounts for 0.78% of the portfolio, ranked #26.

Penserra Capital Management first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Penserra Capital Management held 209,629 shares of Astera Labs worth $101M as of Q2 2026.
  • Penserra Capital Management sold 47,159 Astera Labs shares in Q2 2026, an estimated $12.5M.
  • Astera Labs made up 0.78% of Penserra Capital Management's portfolio in Q2 2026, its #26 holding.
  • Penserra Capital Management first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.